<DOC>
	<DOCNO>NCT00346008</DOCNO>
	<brief_summary>RATIONALE : Studying gene express sample blood patient cancer family member may help doctor identify biomarkers related cancer . PURPOSE : This clinical trial study gene identify melanoma patient Iceland family member .</brief_summary>
	<brief_title>Studying Genes Identify Melanoma Patients Iceland Their Family Members</brief_title>
	<detailed_description>OBJECTIVES : - Assess feasibility Iceland Genomics Corporation ( UVS ) identify melanoma multiple-case family , individual multiple tumor , select additional family member Iceland . - Assess feasibility mutation detection use sequence HPLC . - Determine UVS ' ability create datasets demographic , epidemiologic molecular data . OUTLINE : Participants patient undergo blood collection complete lifestyle questionnaire . All patient population-based control DNA sample sequence MC1R . Demographic epidemiologic data study participant collect . Sequencing major melanoma susceptibility gene CFDKN2A , CDK4 , MC1R also perform .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Patients diagnose melanoma select family member eligible participate Must live Iceland PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>melanoma</keyword>
	<keyword>recurrent melanoma</keyword>
	<keyword>stage I melanoma</keyword>
	<keyword>stage II melanoma</keyword>
	<keyword>stage III melanoma</keyword>
	<keyword>stage IV melanoma</keyword>
</DOC>